Board of Directors
Chair of the Board – Dr. Steven Chatfield
Steve brings over 40 years of experience in life sciences, having held executive and board-level positions across the private and public sectors. His expertise spans the research, development, manufacturing, and commercialisation of vaccines, including emergency preparedness for pandemics, emerging diseases, and bioterrorism threats. During the COVID-19 pandemic, Steve served as an advisor to the UK Vaccines Task Force and now provides strategic counsel to life science companies, academia, and government bodies. He currently serves on the boards of several UK based companies.
CEO - Richard Bungay
Richard was formerly Chief Executive Officer of AIM-listed Diurnal Group plc, where he led the sale of the company to Neurocrine Biosciences in October 2023. Richard has over 25 years’ experience in senior roles in the biotechnology and pharmaceutical sectors, including as CFO and COO at Mereo Biopharma and CEO of Chroma Therapeutics. Richard has been involved in fundraisings totalling over $250 million, along with the negotiation and execution of multiple business development deals. Richard also has extensive experience of taking novel drugs from research through to clinical development and commercialisation and has been involved with the development of six currently marketed drugs, including three novel biological agents. Richard qualified with Deloitte as a Chartered Accountant and has a First Class degree in Chemistry from Nottingham University. Richard is a Non-executive Director of AIM-listed Cambridge Cognition and it's spin-out Monument Therapeutics.
​
​
Non-executive Director - Harry Destecroix
Harry is a supramolecular chemist and CEO of Science Creates Ventures and Incubators. Previously, he was the founder and former CEO of Ziylo Ltd, a business he successfully grew and exited, within four years of founding, in a Share Purchase Agreement to Novo Nordisk A/S, for a potential earnout of $800m. Harry founded the Science Creates incubators in Bristol’s St Philips and Old Market districts that help support the current deep tech ecosystem. In the process of establishing the incubators, he has helped multiple spin outs to emerge, advising them on strategy and helping them build the initial team. Harry sits on the University of Bristol Investment Committee.